Can I read YCT-529: Safety in Phase 1 Clinical Trial on EtoBox?

YCT-529: Safety in Phase 1 Clinical Trial by Kedir Kedir Darwin is a document available to read on EtoBox.

What is YCT-529: Safety in Phase 1 Clinical Trial about?

YCT-529 is a non-hormonal oral male contraceptive being developed to reduce sperm count by inhibiting retinoic acid signaling. A Phase 1a clinical trial demonstrated that YCT-529 was well tolerated with no adverse effects on heart rate, hormone levels, or mood among 16 healthy male participants. The positive safety results support further studies to evaluate its long-term effects on sperm parameters.

Author

Kedir Kedir Darwin

Language

EN